Zyprexa (olanzapine) is an antipsychotic medication for the treatment of schizophrenia and bipolar disorders. Approved by the FDA and released to the market in 1996, Zyprexa was marketed by manufactured Eli Lily as a safe and effective drug for patients with serious psychotic conditions and quickly became as strong seller for the pharmaceutical company.
However, overshadowing Zyprexa’s promising future as a helpful antipsychotic have been the drug’s dangerous reported side effects, ranging from severe weight gain and increases in cholesterol to higher blood-sugar levels and the onset of diabetes.
Not surprisingly, thousands of lawsuits are pending against Eli Lily. They cite not only the manufacturer’s negligence in delivering more clear warnings about potentially severe side effects once issues were known, but for the all-too-common promotion of drugs like Zyprexa for uses not approved by the FDA and which have not yet been determined safe and effective.
It’s another case of too little too late. U.S. drug manufacturers have a responsibility to protect consumers and to deliver honest warnings about each drug’s potentially hazardous side effects, whether those are known before the drug is released to market or come to light after the fact.
If you have used Zyprexa to help control a psychotic and experienced any of the adverse effects mentioned above, please call us for more information. Like thousands of other Zyprexa users already pursuing legal action, you, too, may have a case against Eli Lily.